NZS Capital LLC Sells 2,770 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

NZS Capital LLC trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 4.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 63,550 shares of the medical equipment provider's stock after selling 2,770 shares during the period. Intuitive Surgical accounts for 1.4% of NZS Capital LLC's portfolio, making the stock its 26th largest holding. NZS Capital LLC's holdings in Intuitive Surgical were worth $33,171,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. M.E. Allison & CO. Inc. bought a new position in shares of Intuitive Surgical in the fourth quarter worth about $449,000. Seilern Investment Management Ltd purchased a new position in Intuitive Surgical in the 4th quarter worth approximately $82,517,000. Sycomore Asset Management boosted its stake in Intuitive Surgical by 27.4% in the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock worth $9,214,000 after purchasing an additional 4,079 shares during the period. Exome Asset Management LLC grew its holdings in Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider's stock valued at $3,649,000 after buying an additional 1,069 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. raised its position in shares of Intuitive Surgical by 5.6% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock valued at $5,138,000 after buying an additional 525 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Trading Up 2.5 %

Shares of NASDAQ ISRG traded up $13.15 during midday trading on Friday, hitting $530.33. The company's stock had a trading volume of 844,004 shares, compared to its average volume of 1,619,108. Intuitive Surgical, Inc. has a 12-month low of $367.39 and a 12-month high of $616.00. The firm has a market cap of $190.08 billion, a P/E ratio of 82.73, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. The business's 50 day moving average is $505.20 and its two-hundred day moving average is $533.22.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. The business had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same quarter last year, the firm posted $1.50 earnings per share. On average, analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, VP Fredrik Widman sold 810 shares of Intuitive Surgical stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $464,761.80. Following the completion of the sale, the vice president now directly owns 473 shares of the company's stock, valued at $271,397.94. The trade was a 63.13 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Jamie Samath sold 188 shares of the stock in a transaction on Friday, February 28th. The stock was sold at an average price of $566.94, for a total value of $106,584.72. Following the transaction, the chief financial officer now directly owns 7,162 shares in the company, valued at $4,060,424.28. The trade was a 2.56 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 33,313 shares of company stock worth $17,229,143 in the last 90 days. 0.70% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

ISRG has been the subject of several research analyst reports. Raymond James raised their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an "outperform" rating in a research note on Friday, January 24th. Evercore ISI reduced their target price on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a report on Wednesday, April 23rd. Royal Bank of Canada decreased their target price on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. UBS Group raised their price target on Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a report on Monday, January 27th. Finally, Citigroup upped their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the stock a "buy" rating in a report on Friday, January 24th. Five analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $598.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.